BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21057183)

  • 1. Different approaches in the molecular analysis of the SHOX gene dysfunctions.
    Stuppia L; Gatta V; Antonucci I; Giuliani R; Palka G
    J Endocrinol Invest; 2010 Jun; 33(6 Suppl):30-3. PubMed ID: 21057183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the first recurrent PAR1 deletion in Léri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer.
    Benito-Sanz S; Royo JL; Barroso E; Paumard-Hernández B; Barreda-Bonis AC; Liu P; Gracía R; Lupski JR; Campos-Barros Á; Gómez-Skarmeta JL; Heath KE
    J Med Genet; 2012 Jul; 49(7):442-50. PubMed ID: 22791839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular evaluation of SHOX/PAR1 duplications in Leri-Weill dyschondrosteosis (LWD) and idiopathic short stature (ISS).
    Benito-Sanz S; Barroso E; Heine-Suñer D; Hisado-Oliva A; Romanelli V; Rosell J; Aragones A; Caimari M; Argente J; Ross JL; Zinn AR; Gracia R; Lapunzina P; Campos-Barros A; Heath KE
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E404-12. PubMed ID: 21147883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHOX gene defects and selected dysmorphic signs in patients of idiopathic short stature and Léri-Weill dyschondrosteosis.
    Hirschfeldova K; Solc R; Baxova A; Zapletalova J; Kebrdlova V; Gaillyova R; Prasilova S; Soukalova J; Mihalova R; Lnenicka P; Florianova M; Stekrova J
    Gene; 2012 Jan; 491(2):123-7. PubMed ID: 22020182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability.
    Jorge AA; Souza SC; Nishi MY; Billerbeck AE; Libório DC; Kim CA; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):130-5. PubMed ID: 17201812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SHOX region and its mutations.
    Capone L; Iughetti L; Sabatini S; Bacciaglia A; Forabosco A
    J Endocrinol Invest; 2010 Jun; 33(6 Suppl):11-4. PubMed ID: 21057179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular characterization of Chilean patients with Léri-Weill dyschondrosteosis.
    Rodríguez FA; Unanue N; Hernandez MI; Basaure J; Heath KE; Cassorla F
    J Pediatr Endocrinol Metab; 2013; 26(7-8):729-34. PubMed ID: 23729538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the first de novo PAR1 deletion downstream of SHOX in an individual diagnosed with Léri-Weill dyschondrosteosis (LWD).
    Barroso E; Benito-Sanz S; Belinchón A; Yuste-Checa P; Gracia R; Aragones A; Campos-Barros A; Heath KE
    Eur J Med Genet; 2010; 53(4):204-7. PubMed ID: 20412871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.
    Benito-Sanz S; Aza-Carmona M; Rodríguez-Estevez A; Rica-Etxebarria I; Gracia R; Campos-Barros A; Heath KE
    Eur J Hum Genet; 2012 Jan; 20(1):125-7. PubMed ID: 22071895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic molecular analyses of SHOX in Japanese patients with idiopathic short stature and Leri-Weill dyschondrosteosis.
    Shima H; Tanaka T; Kamimaki T; Dateki S; Muroya K; Horikawa R; Kanno J; Adachi M; Naiki Y; Tanaka H; Mabe H; Yagasaki H; Kure S; Matsubara Y; Tajima T; Kashimada K; Ishii T; Asakura Y; Fujiwara I; Soneda S; Nagasaki K; Hamajima T; Kanzaki S; Jinno T; Ogata T; Fukami M;
    J Hum Genet; 2016 Jul; 61(7):585-91. PubMed ID: 26984564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of MLPA in the detection of SHOX deletions.
    Funari MF; Jorge AA; Souza SC; Billerbeck AE; Arnhold IJ; Mendonca BB; Nishi MY
    Eur J Med Genet; 2010; 53(5):234-8. PubMed ID: 20538086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duplications upstream and downstream of SHOX identified as novel causes of Leri-Weill dyschondrosteosis or idiopathic short stature.
    Bunyan DJ; Baffico M; Capone L; Vannelli S; Iughetti L; Schmitt S; Taylor EJ; Herridge AA; Shears D; Forabosco A; Coviello DA
    Am J Med Genet A; 2016 Apr; 170A(4):949-57. PubMed ID: 26698168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of SHOX gene aberrations in routine diagnostic practice and evaluation of phenotype scoring form effectiveness.
    Hirschfeldova K; Florianova M; Kebrdlova V; Urbanova M; Stekrova J
    J Hum Genet; 2017 Feb; 62(2):253-257. PubMed ID: 27708272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHOX interacts with the chondrogenic transcription factors SOX5 and SOX6 to activate the aggrecan enhancer.
    Aza-Carmona M; Shears DJ; Yuste-Checa P; Barca-Tierno V; Hisado-Oliva A; Belinchón A; Benito-Sanz S; Rodríguez JI; Argente J; Campos-Barros A; Scambler PJ; Heath KE
    Hum Mol Genet; 2011 Apr; 20(8):1547-59. PubMed ID: 21262861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of SHOX and associated elements duplications distribution between patients (Lėri-Weill dyschondrosteosis/idiopathic short stature) and population sample.
    Hirschfeldova K; Solc R
    Gene; 2017 Sep; 627():164-168. PubMed ID: 28629824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of DNA binding, dimerization, and nuclear translocation of SHOX homeodomain mutations identified in idiopathic short stature and Leri-Weill dyschondrosteosis.
    Schneider KU; Marchini A; Sabherwal N; Röth R; Niesler B; Marttila T; Blaschke RJ; Lawson M; Dumic M; Rappold G
    Hum Mutat; 2005 Jul; 26(1):44-52. PubMed ID: 15931687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short stature caused by isolated SHOX gene haploinsufficiency: update on the diagnosis and treatment.
    Jorge AA; Funari MF; Nishi MY; Mendonca BB
    Pediatr Endocrinol Rev; 2010 Dec; 8(2):79-85. PubMed ID: 21150837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of different SHOX gene deletions in patients with Leri-Weill dyschondrosteosys by MLPA assay.
    Gatta V; Antonucci I; Morizio E; Palka C; Fischetto R; Mokini V; Tumini S; Calabrese G; Stuppia L
    J Hum Genet; 2007; 52(1):21-27. PubMed ID: 17091221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 15 novel partial SHOX deletions and 13 partial duplications, and a review of the literature reveals intron 3 to be a hotspot region.
    Benito-Sanz S; Belinchon-Martínez A; Aza-Carmona M; de la Torre C; Huber C; González-Casado I; Ross JL; Thomas NS; Zinn AR; Cormier-Daire V; Heath KE
    J Hum Genet; 2017 Feb; 62(2):229-234. PubMed ID: 27604558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prevalence of SHOX gene deletion in children with idiopathic short stature. A multicentric study].
    Dávid A; Butz H; Halász Z; Török D; Nyirő G; Muzsnai Á; Csákváry V; Luczay A; Sallai Á; Hosszú É; Felszeghy E; Tar A; Szántó Z; Fekete GL; Kun I; Patócs A; Bertalan R
    Orv Hetil; 2017 Aug; 158(34):1351-1356. PubMed ID: 28823207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.